...
首页> 外文期刊>Japanese Journal of Pharmacology >Effects of Various Drugs on Superoxide Generation, Arachidonic Acid Release and Phospholipase A2 in Polymorphonuclear Leukocytes
【24h】

Effects of Various Drugs on Superoxide Generation, Arachidonic Acid Release and Phospholipase A2 in Polymorphonuclear Leukocytes

机译:多种药物对多形核白细胞超氧化物生成,花生四烯酸释放和磷脂酶A2的影响

获取原文
   

获取外文期刊封面封底 >>

       

摘要

References(43) Cited-By(24) The effects of variety of drugs on metabolic burst and phospholipase A2 in polymorphonuclear leukocytes (PMNs) were investigated. The stimulation of PMNs by n-formyl-methionyl-leucyl-phenylalanine (FMLP) causes arachidonic acid (AA) to be released in the cells concomitantly with the generation of superoxide anion. These variables were effectively diminished with some clinically employed drugs including chlorpromazine, trifluoperazine, azelastine, clemastine and mepacrine at the lower concentration of 20 μM. In contrast, indomethacin and procaine were ineffective even at the higher concentration of 100 μM. Subcellular fractionation of PMNs revealed that phospholipase A2 activity was located both in the plasma membrane-rich fraction as well as the granule-microsome-rich fraction, and the potency of inhibition of membrane-bound phospholipase A2 by the above mentioned drugs was: indomethacin (IC50=3 μM)chlorpromazineazelastine and clemastine (IC50100 μM). The low potency of antipsychotropic drugs and antihistaminic drugs in inhibiting the fractionated phospholipase A2 contrast with the high efficiency with which they inhibit the superoxide generation and the AA release from stimulated PMNs. The AA relaeses from the PMNs stimulated by FMLP or calcium ionophore (A23187) were almost equally diminished by various drugs at the lower concentration. From these obsevations, it appeared likely that these drugs might inhibit the metabolic stimulations of PMNs at the sites of the Ca2+-dependent activation processes of the enzymes responsible for the AA release and the superoxide generation.
机译:参考文献(43)Cited-By(24)研究了多种药物对多形核白细胞(PMNs)代谢爆发和磷脂酶A2的影响。 n-甲酰基-甲硫酰基-亮氨酰-苯丙氨酸(FMLP)对PMN的刺激会导致花生四烯酸(AA)在细胞中释放,并产生超氧阴离子。使用一些临床使用的药物(包括氯丙嗪,三氟拉嗪,氮卓斯汀,clemastine和mepacrine)以较低的20μM浓度有效地减少了这些变量。相反,吲哚美辛和普鲁卡因即使在100μM的较高浓度下也无效。 PMNs的亚细胞分级显示磷脂酶A2活性既位于血浆膜富集级分中,也位于富含颗粒微粒体的级分中,并且上述药物对膜结合磷脂酶A2的抑制能力为:消炎痛( IC50 = 3μM)<氯丙嗪<氮卓斯汀和clemastine(IC50> 100μM)。抗精神病药和抗组胺药抑制分级磷脂酶A2的效能低下,与它们抑制过氧化物生成和受刺激PMN释放AA的高效率形成鲜明对比。 FMLP或钙离子载体(A23187)刺激PMN产生的AA残基几乎被各种浓度较低的药物所减少。从这些观察中,似乎这些药物可能在负责AA释放和超氧化物产生的酶的Ca 2+依赖性活化过程的位点抑制PMN的代谢刺激。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号